# Nitto Avecia Pharma Services, Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/nitto-avecia-pharma-services-inc/70750fbf-f816-44e6-aeea-e31b27478b84

> Inspection records and compliance data for Nitto Avecia Pharma Services, Inc. in Irvine, California. Access full analysis and detailed observations.

---

## Details

- Name: Nitto Avecia Pharma Services, Inc.
- FEI Number: 3012971227
- City: Irvine
- State: California
- Country Name: United States
- Address Line 1: 10 Vanderbilt
- Zip Code: 92618
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK

## Related Documents

- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/1bbaf13c-7ea5-4f33-b74a-1380e1198f70) — source: FDA, date: July 25, 2025
- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/b0126f6f-d594-4062-9af6-93553b87f76a) — source: FDA, date: July 25, 2025
- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/aed2547e-f607-4ccb-9712-cd6e0e5d8bee) — classification: No Action Indicated (NAI), source: FDA, date: July 25, 2025
- [FDA Inspection 1279210 - Nitto Avecia Pharma Services, Inc. - 2025-07-25](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/b52f8040-90ed-46af-b162-1e8167e5a831) — classification: No Action Indicated (NAI), source: FDA, date: July 25, 2025
- [FDA Inspection 1220658 - Nitto Avecia Pharma Services, Inc. - 2023-09-22](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/b451d987-e5ea-41d0-ba06-05f294a68fb2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2023
- [483 - Nitto Avecia Pharma Services, Inc. - 2023-09-18](https://www.globalkeysolutions.net/records/483/nitto-avecia-pharma-services-inc/4bbe0fcc-fc6d-4cd7-830e-ce3bcce6fb5a) — source: FDA, date: September 18, 2023
- [483 - Nitto Avecia Pharma Services, Inc. - 2020-01-24](https://www.globalkeysolutions.net/records/483/nitto-avecia-pharma-services-inc/68c42b34-1b01-4013-a3d4-d115b1a05740) — source: FDA, date: January 24, 2020
- [FDA Inspection 1116308 - Nitto Avecia Pharma Services, Inc. - 2020-01-24](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/7f58b95d-2a36-4247-8e45-9c7ba96b1e1a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2020
- [EIR - Nitto Avecia Pharma Services, Inc. - 2019-09-06](https://www.globalkeysolutions.net/records/eir/nitto-avecia-pharma-services-inc/1ba19846-b0eb-47eb-9047-b05d3b192153) — source: FDA, date: September 6, 2019
- [EIR - Nitto Avecia Pharma Services, Inc. - 2019-09-06](https://www.globalkeysolutions.net/records/eir/nitto-avecia-pharma-services-inc/72123f93-991a-478a-bcc1-551bdc8a6372) — source: FDA, date: September 6, 2019
- [FDA Inspection 1103011 - Nitto Avecia Pharma Services, Inc. - 2019-09-06](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/f0e69d85-89ad-4f4c-b63d-19a11e081b56) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2019
- [FDA Inspection 1011375 - Nitto Avecia Pharma Services, Inc. - 2017-04-21](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/20a13d9e-01dd-4da5-992a-d94d25b49fd1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2017
- [FDA Inspection 921085 - Nitto Avecia Pharma Services, Inc. - 2015-04-03](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/3c82c4fc-6519-4ff0-a2dd-0572e96da560) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 3, 2015
- [FDA Inspection 915555 - Nitto Avecia Pharma Services, Inc. - 2015-02-20](https://www.globalkeysolutions.net/records/fda_inspections/nitto-avecia-pharma-services-inc/b5b29701-9625-4d2c-a87a-8f460ea57f9d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2015

## Related Companies

- [Viatris Inc.](https://www.globalkeysolutions.net/companies/viatris-inc/e65d242e-4279-4e07-992f-5f241792c2cf)
- [Lloyd Inc. of Iowa](https://www.globalkeysolutions.net/companies/lloyd-inc-of-iowa/b4573054-1b28-4619-88ea-c42615aede75)
- [Charles River Laboratories, Inc.](https://www.globalkeysolutions.net/companies/charles-river-laboratories-inc/b007c718-aa18-4f77-84ea-4d96765ed0e6)
- [Applied Consumer Services Inc.](https://www.globalkeysolutions.net/companies/applied-consumer-services-inc/04d6a6af-783b-4c67-bb1d-d281131c548e)
- [Emergent Biosolutions LLC](https://www.globalkeysolutions.net/companies/emergent-biosolutions-llc/a4e71e63-5d44-4dd7-a589-a755c72b0637)
- [Fresenius Kabi USA, LLC](https://www.globalkeysolutions.net/companies/fresenius-kabi-usa-llc/1fd32611-ab9e-438a-9ee6-59d3a913d3a3)
- [Gram Laboratories Inc](https://www.globalkeysolutions.net/companies/gram-laboratories-inc/f54a2075-d931-4c44-a97c-e63f05375d9a)
- [ACTA Laboratories, Inc.](https://www.globalkeysolutions.net/companies/acta-laboratories-inc/215a2fac-a2d0-4b2e-b8ca-8c9abe4cbb7d)
- [Chiesi Farmaceutici S.p.A.](https://www.globalkeysolutions.net/companies/chiesi-farmaceutici-spa/c5c5e25e-4e01-482a-b5b3-7a7b11458a67)
- [Nexus Pharmaceuticals, LLC](https://www.globalkeysolutions.net/companies/nexus-pharmaceuticals-llc/9f6c2dd9-2ee0-4492-bcaf-992ff47330cf)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/adam-fox/73741c7d-64d6-4630-a0cc-c33a114cab81)
- [company_representative](https://www.globalkeysolutions.net/people/yvette-tanner/7825c08a-073a-4edb-ae06-44170fbfb5b5)
- [Compliance Officer](https://www.globalkeysolutions.net/people/rumany-c-penn/021eb1e0-8de0-403f-9596-3e76624b2e5a)
- [Claudia M. Perez-Kasmarski](https://www.globalkeysolutions.net/people/claudia-m-perez-kasmarski/ee989ba2-eb7a-47ae-8be5-7a28f748343b)
